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I. ABSTRACT 
Heterochromatic pathways play a key role in the regulation of the genetic code. While there 
are numerous pathways that achieve the inactivation of specific genes, some have been 
evolutionarily conserved due to their effectiveness. One of the best examples of this is concept is 
Heterochromatin Protein 1 (HP1), which has been found to be a versatile protein that serves various 
roles across the genome. There are 3 different HP1 isoforms known to date: CBX5 (HP1α), CBX1 
(HP1), and CBX3 (HP1) that despite their similarities have been reported to behave differently. 
In this study, our aim is to determine the interplay between the identity of HP1 isoforms and their 
effect on the velocity and memory of gene repression. For this, we used a chromatin in vivo assay 
(CiA) system to chemically recruit HP1 to a reporter gene and study its effect. Our experimental 
data support the established notion that HP1α is a more efficient repressor than the other isoforms. 
Due to the collaborative relationship between biochemical activity, gene repression, and cellular 
memory, we believe that investigation of HP1 behavior can be relevant for the development of 
therapeutic drugs to treat genetically-linked diseases in which epigenetic misregulation often has 
a significant effect. 
 
II. INTRODUCTION 
The field of epigenetics revolves around post-transcriptional modifications and their effect 
on overall gene expression. Such modifications regulate the status of chromatin, a dynamic 
complex that consists of DNA strands wrapped around a tetramer of histone proteins, which in 
turn dictates the accessibility of a gene for transcription (Venkatesh & Workman, 2015). The less 
compacted and more accessible euchromatin state allows for the interaction of RNA polymerases 
with the DNA template leading to gene activation, while heterochromatin restricts such access by 
adopting a more condensed and inaccessible conformation (Zhang & Reinberg, 2001). These states 
are achieved through the manifestation of chromatin modifications, such as methylation, 
acetylation, and phosphorylation, which play a key role in regulating transcriptional programs in 
cells. These regulatory processes often act in concert with one another, leading to a network of 
epigenetic marks that can activate or deactivate genes depending on the context (Tongprasit et al., 
2008). For instance, trimethylation of histone 3 at its lysine 27 tail (H3K27me3) has been reported 
to lead to gene repression, yet the same mark at lysine 4  (H3K4me3) has been correlated with 
gene activation (Tongprasit et al., 2008).  
Accordingly, these subtle but instrumental differences in the nature of a given post-
transcriptional mark are essential for the proper regulation of genes. If improper activation and 
inactivation of genes occurs, the consequences can be detrimental. Notably, this concept has 
become an important target for the understanding of oncogenesis, given that many types of cancer 
have been associated with alterations in epigenetic pathways. For example, malignant follicular 
lymphoma contains mutations of a histone methyltransferase in about 90% of the cases (Morin et 
al., 2011), DNA hypermethylation has been reported in the silencing of tumor suppressor genes  
(Jones, 2012) and studies of heterochromatin protein 1 (HP1) have demonstrated that modulation 
of this protein alters the invasive potential of breast cancer cells (Norwood et al., 2006). However, 
even though extensive research has been dedicated to studying these epigenetic marks and 
pathways, the development of effective therapeutic targets has been challenged by the promiscuity 
of the proteins involved in gene regulation.  
One of these versatile proteins is HP1: the first non-histone structural component of 
heterochromatin to be isolated and that is widely known for its role in the establishment and 
maintenance of higher-order chromatin structures (Singh, 2010). The HP1 proteins, of which three 
mammalian isoforms are known, are encoded by chromobox (CBX) genes. These isoforms are 
known as HP1α, HP1, and HP1 and are encoded by CBX5, CBX1, and CBX3, respectively 
(Lomberk, Wallrath, & Urrutia, 2006). These proteins possess a characteristic genetic sequence 
that has been greatly conserved in many organisms, ranging from Drosophila to mice and humans 
(Vermaak, Henikoff, & Malik, 2005), indicating that the specific interactions that arise from the 
transcription, and subsequent translation of such sequences into amino acids contribute an 
evolutionary advantage. The main organization of the CBX genes comprises an N-terminus 
extension (NTE), a chromo-domain (CD), a middle hinge region, a chromoshadow domain (CSD), 
and a C-terminus extension (CTE), sequentially (Singh, 2010). The chromodomain is known to 
encode the site responsible for HP1 binding to H3K9me2/3, while the chromoshadow is involved 
in homo- and/or heterodimerization and interaction with other proteins (Lomberk et al., 2006). 
These two areas are very similar among the three isoforms with over 70% identity, while the hinge 
region contains the most variable sequences of amino acids and has been shown to highly influence 
the localization, interactions, and function of each isoform (Lomberk et al., 2006) (Fig 1). 
Figure 1. Alignment of amino acid sequence for all 3 HP1 isoforms' full-length protein. 
Interestingly, despite what its name suggests, HP1 is not exclusively present in 
heterochromatic regions and its only role is not to silence genes. Studies have made clear that these 
proteins have additional nuclear functions, including transcriptional activation and elongation, 
chromosome segregation, DNA repair, sister chromatid cohesion, and RNA splicing (Canzio, 
Larson, & Narlikar, 2014). As a result, HP1 is dispersed throughout the genome, with different 
isoforms concentrating in distinct regions. For example, HP1α and HP1 have been primarily 
associated with heterochromatic locations such as telomeres and centromeres, while HP1 has 
been largely found in euchromatic regions playing a role in transcriptional elongation (Canzio et 
al., 2014). Thus, although the HP1 paralogs possess very similar genetic constructs, they seem to 
perform different functions and have specific genomic zones of influence where their subtle 
structural differences potentially enhance or diminish their efficiency. 
 In this project, we aim to study the interplay between the identity of the HP1 isoform and 
its effect on the velocity and memory of gene repression. To achieve this, we used the chromatin 
in vivo assay (CiA) system as described in Hathaway et al., 2012 to chemically recruit HP1 to a 
reporter gene. HP1 paves the way for the formation of heterochromatic domains by luring histone 
methyltransferases (HMTs) that insert H3K9 methyl marks, DNA methyltransferases (DNMTs) 
that methylate CpG dinucleotides within DNA, and other HP1 proteins that propagate these signals 
to neighboring nucleosomes (Fig 1). The CiA system enabled us to selectively repress the reporter 
gene and, this way, test the contribution of each HP1 isoform to cellular memory and stability after 
HP1 is removed.  
 III. MATERIALS AND METHODS 
Cell culture  
Three MEF cell line with a reporter nucEGFP under control of a CMV/EF1α promoter and 
adjacent to a 5x array of Gal4 DNA binding site (Vignaux et al., 2019-in review) were grown in 
FBS-supplemented growth media as described in (Butler, Chiarella, Jin, & Hathaway, 2018) and 
selected with 9 g/mL blasticidin and 6.5 g/mL puromycin to drive csHP1(α, , )-Frb and 
FKBP-Gal4 expression.  
Lentiviral Infections 
293T LentiX cells (Clontech) were transfected using polyethyleneimine with each of the 
chromoshadow-Fbr constructs and the Gal4-FKBP fusion proteins. 
CIP Heterochromatin Assay 
Antibiotic selection was removed from cells the day before experimentation. The chemical 
inducer of proximity rapamycin was added to the medium at a 3 nM concentration (3 L of a 10 
M stock solution per 10 mL of media). 
Figure 2. Visual model for HP1-mediate heterochromatin formation mechanism. HP1 recognizes the H3K9me3 site and, after 
binding, recruits HMTs, DNMTs, and other endogenous HP1 proteins. 
Removal of CIP and EGFP Re-expression 
The removal of rapamycin was achieved by adding FK506 at a 100 nM concentration (10 
L of a 100 M stock solution per 10 mL of media) for 48 hours. For the remainder of the time, 
the cells were allowed to grow in drug-free media. 
Flow Cytometry  
Flow cytometry was performed on an Attune Nxt in biological triplicates. The samples 
were later analyzed using FlowJo software, where the data was gated to include only live, single, 
and non-autofluorescent cells. The number of cells included in the data was normalized to the 
sample with the lowest population count through randomized down-sampling. 
Statistical Analysis 
Statistical analyses were performed using GraphPad Prism 7 software. Replicates from 
flow cytometry were subjected to 2-way ANOVA tests, and discoveries were determined using  
the Geisser-Greenhouse correction. 
 
IV. RESULTS  
In order to compare and contrast the repressive pathways of each HP1 isoform and their 
individual effect on heterochromatin formation velocity and memory, 3 different cell lines were 
created. Each clonal line was designed to chemically recruit the chromoshadow domain (CSD) of 
the specific isoform, giving rise to the lines that in this study will be referred to as HP1α, HP1, 
and HP1. To quantify gene expression, we used CRISPR/Cas9 gene editing to insert a nucEGFP 
gene driven by a promoter comprised of a CMV enhancer and a core EF1α promoter sequence. 
The reporter complex was incorporated outside of the Hbb- gene in the -globin locus in the 
mouse genome of large T-transformed mouse embryonic fibroblasts (MEFs).   
We induced heterochromatin formation at this locus by using the CiA system, which uses 
a chemical inducer of proximity (CIP) to recruit fusion proteins that reversibly tether the 
chromoshadow of HP1 (csHP1) to the site. The binding of the CIP rapamycin to FKBP (FK506 
binding protein) will allow for the subsequent binding of a Frb (FKBP-rapamycin binding) domain 
with which csHP1 is tagged for recruitment to the CiA locus (Fig 2) (Hathaway et al., 2012). After 
CIP addition, the recruited exogenous csHP1 to the site to lure endogenous HP1 proteins, HMTs, 
and DNMTs, which act in concert to establish a heterochromatic domain. Conveniently, because 
the domain is formed as a result of CIP bridging, this effect can be easily reversed through the 
addition of FK506, which effectively displaces rapamycin and csHP1 by binding to FKBP, but not 
to Frb (Fig 2).  Since csHP1 can be removed, the epigenetic stability and memory of repression 
can be studied given that the domain would need to be maintained by the cell’s own machinery.  
  
Heterochromatin formation in the three cell lines was monitored by the expression of green 
fluorescent protein (GFP), which was quantified through flow cytometry analysis. Expression 
levels after CIP addition were measured for 6 consecutive days. Based on the results, all the cell 
Figure 3. Visual representation of the Chromatin in vivo Assay (CiA), activated by the chemical inducer of proximity rapamycin. 
lines experienced about 50% reduction in expression levels after 1 day of csHP1 recruitment and 
almost complete repression after 6 days (Fig 4, 5A, 5B). Although the baseline levels of GFP 
expression were different for the 3 cell lines, they all showed similar trends of silencing. These 
data show that the structural differences between the isoforms are not enough to cause an impactful 
change in heterochromatization velocity. 
Following the 6 days of repression, we proceeded to remove the tethered csHP1 complexes 
by adding FK506 for 48 hours. We then performed flow cytometry for 6 additional days, which 
allowed us to juxtapose the stability of the heterochromatic domain established in each of the cell 
lines by evaluating their velocities of re-expression. Interestingly, while HP1 and HP1 reported 
similar velocities of GFP expression recovery, HP1α displayed a substantially slower rate of re-
expression (Fig. 4, 5C, 5D) By Day 4, the HP1α cell line had recovered about 26% of its baseline 
expression level, while HP1 and HP1 recuperated 81% and 67%, respectively (Fig. 2). However, 
6 days was not enough for any of the cell lines to completely reach baseline GFP expression values, 
as represented by the dotted horizontal lines in Fig 5C & 5D.  
 
 
Figure 4. Histogram representation of GFP expression after csHP1 recruitment (left) and release (right). In the legends for the 
heterochromatin formation histograms, “Days” label refers to days of csHP1 recruitment, while on the csHP1 Release legends, 
“Days” label refers to days of csHP1 release. 
 
 
 
Figure 5. (A and B) Graphical representation of GFP expression as a function of time showing the velocity of heterochromatin 
formation for the three isoforms. (C and D) Same as described for A and B, but showing the trend for GFP re-expression. Two-
way ANOVA statistical analysis validates a significant change in expression between days. 
 
V. DISCUSSION 
 This study evaluates the behavior of the 3 known HP1 isoforms after engagement in 
heterochromatin formation by analyzing velocity and memory of repression. Our data reveals that 
while the 3 isoforms showed similar rates of silencing, they display variability in their rates of re-
expression. HP1α was considerably slower than HP1 and HP1 with only a 27% restoration of 
GFP expression after 5 days as opposed to 82% and 73% by the latter two, respectively. It is 
important to note that in previous experiments using the same HP1α cell line, expression was 
restored after 6 days (Vignaux et al., 2019-in review). Nevertheless, our results can, in theory, be 
A C
DB 
explained by analyzing the structural differences between the three isoforms and their typical 
genomic location-specific roles.  
While HP1α is commonly associated with silenced heterochromatic regions, HP1 and 
HP1 have been known to play both gene silencing and activating roles (Larson et al., 2018) 
Studies have proposed that this variability might be due to their differences in their amino acid 
sequence (Fig 1). As mentioned above, the sequence of the HP1 proteins has been highly 
conserved, with all 3 possessing an N-terminal extension (NTE), a chromodomain (CD), a hinge 
region, a chromoshadow domain (CSD), and a C-terminal extension (CTE) (Fig 1). 
Structural biochemical analyses of the isoforms’ CSD suggest that, given their similarities 
in sequence and organization, the CSDs of HP1α/β/γ would recognize histone H3 fragment 
similarly (Loppnau et al., 2017). This supports our finding that the rate of heterochromatin 
formation for all three cell lines was about the same and any difference was indistinguishable. On 
the other hand, when thinking about the more variable regions on the HP1 isoforms complexes, 
we encounter a possible explanation for our re-expression results. Liu et al. report that although 
not necessary for binding, the CTE enhances HP1 affinity to the H3 protein due to its interaction 
with the CSD as it dimerizes with other proteins (Loppnau et al., 2017). This concept is further 
investigated by Mendez et al., who rationalize that HP1α selectivity is derived from the 
cooperation between its CSD and its C-terminal extension (CTE), a mechanism that has resulted 
in preferential interactions with different peptides (Mendez et al., 2011). On the other end of the 
isoforms’ sequence, we can find the NTE, in which important differences have been found; 
namely, that HP1α NTE region contains phosphorylation sites that are absent in HP1 and HP1  
and that have been shown to have a key role in the formation of heterochromatin in cells  
(Hiragami-Hamada et al., 2016). Additionally, another study that examined the structural 
variability of the HP1 isoforms, this time targeting the highly variable hinge region, reported that 
the HP1α hinge region can independently induce heterochromatin (Smothers & Henikoff, 2002). 
In all, structural and biochemical studies support our finding that HP1α forms a potentially 
tighter heterochromatic domain. However, further experimentation would be needed to accurately 
conclude if the delay in the HP1α construct GFP re-expression is due to the cell’s own maintenance 
of the repressive complex, to csHP1α establishing “tighter” heterochromatic domain. In order to 
determine the reason behind these results, a potential future experiment would chromatin 
immunoprecipitation (ChIP). This would aid in the quantification of H3K9me3 enrichment, a 
variable that directly correlates to the activity of csHP1 in the cell. This will tell us if repression is 
being triggered by HP1 or if, potentially, other repressive domains are being recruited by HP1. We 
could also use ChIP to investigate if the introduction of exogenous HP1 isoforms preferentially 
leads to the recruitment of the same endogenous HP1 isoform to the site of heterochromatization 
and, this way, identify any interactions between the isoforms. 
  Afterward, long-term silencing would be a great way to determine whether each isoform is 
able to engage the cell’s own machinery in the maintenance of the heterochromatin after removal 
of HP1. Long term silencing via HP1 recruitment has been shown to engage DNMTs, which 
facilitate the methylation of CpG dinucleotides in the DNA template (Hathaway et al., 2012). 
Because DNA methylation is a mark that is inherited through mitosis and is, therefore, perpetuated 
without the need of csHP1 binding, we will be able to determine if the cell’s molecular machinery 
is being involved in the maintenance of stable heterochromatin and if this engagement is affected 
by the isoform that starts the process (Amabile et al., 2016). A short-term repression experiment 
is not likely to engage the endogenous DNMTs to the point of adding the necessary CpG methyl 
marks required for the development of stable heterochromatic memory. As a result, we could 
identify the differences between short-term and long-term silencing by obtaining bisulfite 
sequencing data, through which we could compare the levels of DNA methylation before 
repression and after short- and long-term exposure to csHP1.  
 
VI. CONCLUSIONS  
In this study, we investigate the interplay between the amino acid sequence of HP1 
isoforms and their effect on the velocity and memory of gene repression. To achieve this, we used 
a chromatin in vivo assay (CiA) system to chemically recruit csHP1to a reporter gene. We 
concluded that while the 3 isoforms are very similar in their amino acid sequence, they have 
different effects on the memory of heterochromatin formation, with HP1α potentially forming a 
tighter heterochromatic domain. Based on our results, we believe that the study of HP1-mediated 
heterochromatin formation can help increase the current understanding of how biochemical 
activity impacts cellular memory and genetic regulation. This can be relevant for the development 
of therapeutic drugs to treat genetically-linked diseases, such as cancer, in which epigenetic 
misregulation often plays a central role. 
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